388:HKEXHong Kong Exchanges & Clearing Ltd. Analysis
Data as of 2026-06-14 - not real-time
MYR 0.85
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Muda Holdings is trading just above its recent support level, with the 20‑day moving average slipping slightly beneath the 50‑day average, hinting at a modest bearish bias. The RSI hovers around the mid‑point, suggesting the stock is neither overbought nor oversold, while the MACD line sits below its signal, reinforcing a bearish technical signal. Volume has been on the rise, providing some liquidity support, but price remains constrained near the upper end of its 52‑week range, facing a clear resistance ceiling.
Fundamentally, the company reports negative profit margins and earnings per share, a high debt load relative to equity, and a low return on equity, all of which weigh on its financial health. Nevertheless, the valuation appears extremely cheap, with price‑to‑book and price‑to‑sales ratios well below one, and a dividend yield in the mid‑single digits supported by a payout ratio under 70%. The combination of cheap valuation and dividend income offers a modest cushion, but the structural profitability challenges and leverage keep upside limited in the near term.
Fundamentally, the company reports negative profit margins and earnings per share, a high debt load relative to equity, and a low return on equity, all of which weigh on its financial health. Nevertheless, the valuation appears extremely cheap, with price‑to‑book and price‑to‑sales ratios well below one, and a dividend yield in the mid‑single digits supported by a payout ratio under 70%. The combination of cheap valuation and dividend income offers a modest cushion, but the structural profitability challenges and leverage keep upside limited in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD histogram
- Price testing resistance near recent highs
- Increasing volume but limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Very low price‑to‑book and price‑to‑sales ratios
- Negative earnings and high leverage
- Dividend yield offering modest income
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Deep valuation discount provides margin of safety
- Potential for operational turnaround to improve margins
- Sustained dividend can support total return if profitability recovers
Key Metrics & Analysis
Financial Health
Revenue Growth-7.50%
Profit Margin-1.95%
ROE-1.95%
ROA-0.37%
Debt/Equity56.14
P/B Ratio0.2
Op. Cash FlowMYR60.5M
Free Cash FlowMYR10.1M
Technical Analysis
TrendNeutral
RSI49.5
SupportMYR 0.81
ResistanceMYR 0.88
MA 20MYR 0.84
MA 50MYR 0.87
MA 200MYR 0.82
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
GradeUndervalued
TypeValue
Dividend Yield2.35%
Risk Assessment
Beta0.16
Volatility44.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.